Danpure C J, Jennings P R, Watts R W
Lancet. 1987 Feb 7;1(8528):289-91. doi: 10.1016/s0140-6736(87)92023-x.
A deficiency of activity of the peroxisomal enzyme alanine:glyoxylate aminotransferase (AGT,EC 2.6.1.44)has been found in the livers of six patients with primary hyperoxaluria type 1 (PH), including three in whom the tissue was obtained by percutaneous needle biopsy. AGT activity, assayed in unfractionated liver tissue, ranged from 11 to 47% of the mean control value, and appeared to be related to the clinical severity of PH and to several biochemical variables which indicate the degree of pathophysiological derangement. There was no difference between patients and controls in the activities of glutamate: glyoxylate aminotransferase (GGT, EC 2.6.1.4) or catalase (EC 1.11.1.6). In the five most severe cases residual AGT activity could be largely accounted for by the crossover from another enzyme, presumably GGT. PH can be diagnosed using percutaneous hepatic needle biopsy and assay of AGT, whose activity may be useful in determining the prognosis and likely severity of the disease.
在6例1型原发性高草酸尿症(PH1)患者的肝脏中,发现过氧化物酶体酶丙氨酸:乙醛酸转氨酶(AGT,EC 2.6.1.44)活性缺乏,其中3例患者的组织是通过经皮肝穿刺活检获取的。在未分级的肝组织中检测到的AGT活性为平均对照值的11%至47%,且似乎与PH的临床严重程度以及一些表明病理生理紊乱程度的生化变量有关。患者与对照之间的谷氨酸:乙醛酸转氨酶(GGT,EC 2.6.1.4)或过氧化氢酶(EC 1.11.1.6)活性无差异。在5例最严重的病例中,残余的AGT活性很大程度上可能是由另一种酶(推测为GGT)的交叉反应所致。经皮肝穿刺活检及AGT检测可用于诊断PH1,AGT活性可能有助于确定该病的预后和可能的严重程度。